Ye, ZK;
Chen, YL;
Chen, K;
Zhang, XL;
Du, GH;
He, B;
Li, DK;
Liu, YN;
Yang, KH;
Zhang, YY;
Zhai, SD.
BACKGROUND: Guideline development should be based on the quality of evidence, balance of benefits and harms, economic evaluation and patients' views and preferences. Therefore, these factors were considered in the development of a new guideline for therapeutic drug monitoring (TDM) of vancomycin. OBJECTI...
Rationale for the guidelines: Since the publication of the WHO Guidelines for the management of sexually transmitted infections in 2003, changes in the epidemiology of STIs and advancements in prevention, diagnosis and treatment necessitate changes in STI management. These guidelines provide updated trea...
Rationale for the guidelines: Since the publication of the WHO Guidelines for the management of sexually transmitted infections in 2003, changes in the epidemiology of STIs and advancements in prevention, diagnosis and treatment necessitate changes in STI management. There is an urgent need to update tre...
Neisseria gonorrhoeae,
Gonorrhea/drug therapy,
Drug Resistance, Microbial,
Cefixime/administration & dosage,
Spectinomycin/administration & dosage,
Ceftriaxone/administration & dosage,
Gentamicins/administration & dosage,
Kanamycin/administration & dosage,
Tetracycline/administration & dosage,
Erythromycin/administration & dosage,
Povidone-Iodine/administration & dosage,
Silver Nitrate/administration & dosage,
Chloramphenicol/therapeutic use,
Anti-Bacterial Agents/administration & dosage,
Drug Therapy, Combination